During the past decade, Natalie Warren Bryant Cancer Center at St. Francis Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 62 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Natalie Warren Bryant Cancer Center at St. Francis Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 40 trials, followed by "Radiation Therapy Oncology Group" with 17 trials sponsored, "Eastern Cooperative Oncology Group" with 16 trials sponsored, "NSABP Foundation Inc" with 12 trials sponsored and "Children's Oncology Group" with 12 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Natalie Warren Bryant Cancer Center at St. Francis Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 113 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "North Central Cancer Treatment Group" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Natalie Warren Bryant Cancer Center at St. Francis Hospital" are "Breast Cancer" (25 trials), "Lung Cancer" (15 trials), "Leukemia" (9 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (9 trials) and "Colorectal Cancer" (8 trials). Many other conditions were trialed in "Natalie Warren Bryant Cancer Center at St. Francis Hospital" in a lesser frequency.

Most popular intervention types in "Natalie Warren Bryant Cancer Center at St. Francis Hospital" are "Drug" (96 trials), "Radiation" (31 trials), "Other" (29 trials), "Biological" (28 trials) and "Procedure" (19 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (17 trials), "cyclophosphamide" (14 trials), "radiation therapy" (14 trials), "gemcitabine hydrochloride" (9 trials) and "paclitaxel" (9 trials). Other intervention names were less common.

The vast majority of trials in "Natalie Warren Bryant Cancer Center at St. Francis Hospital" are 86 trials for "All" genders, 24 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Natalie Warren Bryant Cancer Center at St. Francis Hospital". undefined are not yet recruiting, undefined are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 95 completed trials in Natalie Warren Bryant Cancer Center at St. Francis Hospital, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Natalie Warren Bryant Cancer Center at St. Francis Hospital, 6 "Phase 1" clinical trials were conducted, 52 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".